Ruxolitinib in the management of steroid-resistant/-dependent acute and chronic graft-versus-host disease: results of routine practice in an academic centre View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-11-12

AUTHORS

Garret M. K. Leung, Joycelyn P. Y. Sim, Yu-Yan Hwang, Thomas S. Y. Chan, Albert K. W. Lie, Eric Tse, Yok-Lam Kwong

ABSTRACT

Graft-versus-host disease (GVHD) is an important complication after allogeneic haematopoietic stem cell transplantation (HSCT). Corticosteroids are the standard first-line treatment. Steroid-resistant/-dependent (SR/D) acute and chronic GVHD (aGVHD, cGVHD) lead to significant morbidity/mortality. The JAK2 inhibitor ruxolitinib has recently been shown in clinical trials to be effective in SR/D aGVHD and cGVHD. We retrospectively analysed the efficacy and safety of ruxolitinib in a cohort of SR/D aGVHD and cGVHD patients treated in a non-trial setting. In the aGVHD cohort, there were 14 men and 12 women, median age at 38 (19–63) years. At day 28 post-ruxolitinib, the overall response rate (ORR) was 86% (complete response, CR, 36%; partial response, PR, 50%). Continued ruxolitinib beyond day 28 resulted in a final CR of 68%. However, 3/15 (20%) of CR patients developed cGVHD. In the cGVHD cohort, there were 16 men and 15 women, median age at 33 (21–64) years. The ORR, CR and PR rates changed with continued ruxolitinib treatment, being 86%, 17% and 69% at 1 month; 79%, 38% and 41% at 3 months; and 83%, 52% and 31% at 6 months. Five patients had overlap GVHD, four of whom achieved CR. Multivariate analysis showed that superior overall survival and failure-free survival were associated with CR at day 28 for aGVHD, and CR at 1 year for cGVHD. Ruxolitinib treatment was efficacious for SR/D aGVHD and cGVHD, and continued treatment for at least 6 months was needed to maximize benefit. More... »

PAGES

155-163

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-021-04658-x

DOI

http://dx.doi.org/10.1007/s00277-021-04658-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1142551074

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34767056


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chronic Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Graft vs Host Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Janus Kinase 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nitriles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrimidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Steroids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leung", 
        "givenName": "Garret M. K.", 
        "id": "sg:person.016453003452.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016453003452.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sim", 
        "givenName": "Joycelyn P. Y.", 
        "id": "sg:person.011416733702.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011416733702.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hwang", 
        "givenName": "Yu-Yan", 
        "id": "sg:person.01123355430.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123355430.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chan", 
        "givenName": "Thomas S. Y.", 
        "id": "sg:person.013304036752.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013304036752.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lie", 
        "givenName": "Albert K. W.", 
        "id": "sg:person.010762116764.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010762116764.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tse", 
        "givenName": "Eric", 
        "id": "sg:person.01126550300.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126550300.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China", 
          "id": "http://www.grid.ac/institutes/grid.415550.0", 
          "name": [
            "Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kwong", 
        "givenName": "Yok-Lam", 
        "id": "sg:person.01100514066.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100514066.14"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00277-020-04273-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1132407613", 
          "https://doi.org/10.1007/s00277-020-04273-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s40164-017-0092-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1093138750", 
          "https://doi.org/10.1186/s40164-017-0092-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41409-020-0834-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1124934818", 
          "https://doi.org/10.1038/s41409-020-0834-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2015.212", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052129890", 
          "https://doi.org/10.1038/leu.2015.212"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41409-017-0081-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100512173", 
          "https://doi.org/10.1038/s41409-017-0081-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41409-018-0204-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104393431", 
          "https://doi.org/10.1038/s41409-018-0204-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41409-019-0662-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1120837525", 
          "https://doi.org/10.1038/s41409-019-0662-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41409-017-0068-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100248968", 
          "https://doi.org/10.1038/s41409-017-0068-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41409-019-0731-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1122362913", 
          "https://doi.org/10.1038/s41409-019-0731-x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-11-12", 
    "datePublishedReg": "2021-11-12", 
    "description": "Graft-versus-host disease (GVHD) is an important complication after allogeneic haematopoietic stem cell transplantation (HSCT). Corticosteroids are the standard first-line treatment. Steroid-resistant/-dependent (SR/D) acute and chronic GVHD (aGVHD, cGVHD) lead to significant morbidity/mortality. The JAK2 inhibitor ruxolitinib has recently been shown in clinical trials to be effective in SR/D aGVHD and cGVHD. We retrospectively analysed the efficacy and safety of ruxolitinib in a cohort of SR/D aGVHD and cGVHD patients treated in a non-trial setting. In the aGVHD cohort, there were 14 men and 12 women, median age at 38 (19\u201363) years. At day 28 post-ruxolitinib, the overall response rate (ORR) was 86% (complete response, CR, 36%; partial response, PR, 50%). Continued ruxolitinib beyond day 28 resulted in a final CR of 68%. However, 3/15 (20%) of CR patients developed cGVHD. In the cGVHD cohort, there were 16 men and 15 women, median age at 33 (21\u201364) years. The ORR, CR and PR rates changed with continued ruxolitinib treatment, being 86%, 17% and 69% at 1\u00a0month; 79%, 38% and 41% at 3\u00a0months; and 83%, 52% and 31% at 6\u00a0months. Five patients had overlap GVHD, four of whom achieved CR. Multivariate analysis showed that superior overall survival and failure-free survival were associated with CR at day 28 for aGVHD, and CR at 1\u00a0year for cGVHD. Ruxolitinib treatment was efficacious for SR/D aGVHD and cGVHD, and continued treatment for at least 6\u00a0months was needed to maximize benefit.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00277-021-04658-x", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1358129", 
        "issn": [
          "0939-5555", 
          "1432-0584"
        ], 
        "name": "Annals of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "101"
      }
    ], 
    "keywords": [
      "overall response rate", 
      "haematopoietic stem cell transplantation", 
      "day 28", 
      "host disease", 
      "median age", 
      "ruxolitinib treatment", 
      "allogeneic haematopoietic stem cell transplantation", 
      "standard first-line treatment", 
      "significant morbidity/mortality", 
      "safety of ruxolitinib", 
      "management of steroid", 
      "superior overall survival", 
      "failure-free survival", 
      "first-line treatment", 
      "non-trial setting", 
      "stem cell transplantation", 
      "morbidity/mortality", 
      "JAK2 inhibitor ruxolitinib", 
      "chronic GVHD", 
      "cGVHD patients", 
      "chronic graft", 
      "CR patients", 
      "overall survival", 
      "important complication", 
      "cell transplantation", 
      "PR rate", 
      "clinical trials", 
      "inhibitor ruxolitinib", 
      "academic centers", 
      "response rate", 
      "routine practice", 
      "multivariate analysis", 
      "cGVHD", 
      "patients", 
      "ruxolitinib", 
      "cohort", 
      "months", 
      "GVHD", 
      "treatment", 
      "graft", 
      "disease", 
      "final CR", 
      "women", 
      "survival", 
      "age", 
      "men", 
      "years", 
      "corticosteroids", 
      "complications", 
      "transplantation", 
      "mortality", 
      "steroids", 
      "trials", 
      "efficacy", 
      "rate", 
      "safety", 
      "setting", 
      "management", 
      "center", 
      "benefits", 
      "practice", 
      "analysis", 
      "results", 
      "Cr"
    ], 
    "name": "Ruxolitinib in the management of steroid-resistant/-dependent acute and chronic graft-versus-host disease: results of routine practice in an academic centre", 
    "pagination": "155-163", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1142551074"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-021-04658-x"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34767056"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-021-04658-x", 
      "https://app.dimensions.ai/details/publication/pub.1142551074"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:43", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_914.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00277-021-04658-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-021-04658-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-021-04658-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-021-04658-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-021-04658-x'


 

This table displays all metadata directly associated to this object as RDF triples.

275 TRIPLES      21 PREDICATES      116 URIs      98 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-021-04658-x schema:about N05c25e35fe3f40efb8762ff97239f4f5
2 N0bdb99030e66464fa90841f6ff75e84b
3 N190ab228622a45b6bb41556a481bfdf4
4 N3194d75516314c6cb0ae345299679f12
5 N38ba36bb720547d0a87293fd0c1353e2
6 N4adb93dd858c4385ac787748106569de
7 N69984f048b4749938f794193b4950deb
8 N6feef059ed6c4ae99029b2f50bf72fbb
9 N89c92e3040ae4942b7803718f4e38535
10 N8ab76f4d28a0427b9a901f35dd7097c3
11 N92c6c026c4f64df28d541058592b947c
12 Nc790e47cca1d40dd89889a615062e380
13 Nca85650160484a0db80160ea4c19918d
14 Ncfc2aebad5954c40b4ec9101dc4a6c5a
15 Nd1f2065917bd430fabd822bbbf506fae
16 Nec5ac882f0c1445ba7b0769d18505c20
17 Nf3a185a47b7d49449648808d3942c8a8
18 anzsrc-for:11
19 anzsrc-for:1102
20 anzsrc-for:1103
21 schema:author N7a750e32bb8047e6b3354bad817b9819
22 schema:citation sg:pub.10.1007/s00277-020-04273-2
23 sg:pub.10.1038/leu.2015.212
24 sg:pub.10.1038/s41409-017-0068-2
25 sg:pub.10.1038/s41409-017-0081-5
26 sg:pub.10.1038/s41409-018-0204-7
27 sg:pub.10.1038/s41409-019-0662-6
28 sg:pub.10.1038/s41409-019-0731-x
29 sg:pub.10.1038/s41409-020-0834-4
30 sg:pub.10.1186/s40164-017-0092-3
31 schema:datePublished 2021-11-12
32 schema:datePublishedReg 2021-11-12
33 schema:description Graft-versus-host disease (GVHD) is an important complication after allogeneic haematopoietic stem cell transplantation (HSCT). Corticosteroids are the standard first-line treatment. Steroid-resistant/-dependent (SR/D) acute and chronic GVHD (aGVHD, cGVHD) lead to significant morbidity/mortality. The JAK2 inhibitor ruxolitinib has recently been shown in clinical trials to be effective in SR/D aGVHD and cGVHD. We retrospectively analysed the efficacy and safety of ruxolitinib in a cohort of SR/D aGVHD and cGVHD patients treated in a non-trial setting. In the aGVHD cohort, there were 14 men and 12 women, median age at 38 (19–63) years. At day 28 post-ruxolitinib, the overall response rate (ORR) was 86% (complete response, CR, 36%; partial response, PR, 50%). Continued ruxolitinib beyond day 28 resulted in a final CR of 68%. However, 3/15 (20%) of CR patients developed cGVHD. In the cGVHD cohort, there were 16 men and 15 women, median age at 33 (21–64) years. The ORR, CR and PR rates changed with continued ruxolitinib treatment, being 86%, 17% and 69% at 1 month; 79%, 38% and 41% at 3 months; and 83%, 52% and 31% at 6 months. Five patients had overlap GVHD, four of whom achieved CR. Multivariate analysis showed that superior overall survival and failure-free survival were associated with CR at day 28 for aGVHD, and CR at 1 year for cGVHD. Ruxolitinib treatment was efficacious for SR/D aGVHD and cGVHD, and continued treatment for at least 6 months was needed to maximize benefit.
34 schema:genre article
35 schema:isAccessibleForFree false
36 schema:isPartOf N6a478fec9db2450f993851b5c75d00cc
37 Nc96a2237da9745d49b17fb80e74c3685
38 sg:journal.1358129
39 schema:keywords CR patients
40 Cr
41 GVHD
42 JAK2 inhibitor ruxolitinib
43 PR rate
44 academic centers
45 age
46 allogeneic haematopoietic stem cell transplantation
47 analysis
48 benefits
49 cGVHD
50 cGVHD patients
51 cell transplantation
52 center
53 chronic GVHD
54 chronic graft
55 clinical trials
56 cohort
57 complications
58 corticosteroids
59 day 28
60 disease
61 efficacy
62 failure-free survival
63 final CR
64 first-line treatment
65 graft
66 haematopoietic stem cell transplantation
67 host disease
68 important complication
69 inhibitor ruxolitinib
70 management
71 management of steroid
72 median age
73 men
74 months
75 morbidity/mortality
76 mortality
77 multivariate analysis
78 non-trial setting
79 overall response rate
80 overall survival
81 patients
82 practice
83 rate
84 response rate
85 results
86 routine practice
87 ruxolitinib
88 ruxolitinib treatment
89 safety
90 safety of ruxolitinib
91 setting
92 significant morbidity/mortality
93 standard first-line treatment
94 stem cell transplantation
95 steroids
96 superior overall survival
97 survival
98 transplantation
99 treatment
100 trials
101 women
102 years
103 schema:name Ruxolitinib in the management of steroid-resistant/-dependent acute and chronic graft-versus-host disease: results of routine practice in an academic centre
104 schema:pagination 155-163
105 schema:productId N18271453f0ea499da3242cd348a694a7
106 N2ad94e98ed124ec4bfe37dd5b2853a81
107 N61e8566b10c646dc88e3b78be2ce1974
108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1142551074
109 https://doi.org/10.1007/s00277-021-04658-x
110 schema:sdDatePublished 2022-12-01T06:43
111 schema:sdLicense https://scigraph.springernature.com/explorer/license/
112 schema:sdPublisher N60ca6248b9b246b7a0207b68b3d4bf40
113 schema:url https://doi.org/10.1007/s00277-021-04658-x
114 sgo:license sg:explorer/license/
115 sgo:sdDataset articles
116 rdf:type schema:ScholarlyArticle
117 N05c25e35fe3f40efb8762ff97239f4f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Acute Disease
119 rdf:type schema:DefinedTerm
120 N07ef05031a2b4cada7b406335514a692 rdf:first sg:person.01126550300.26
121 rdf:rest N1c071079223943df9e88fbb22467281b
122 N0bdb99030e66464fa90841f6ff75e84b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Middle Aged
124 rdf:type schema:DefinedTerm
125 N18271453f0ea499da3242cd348a694a7 schema:name doi
126 schema:value 10.1007/s00277-021-04658-x
127 rdf:type schema:PropertyValue
128 N190ab228622a45b6bb41556a481bfdf4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Janus Kinase 2
130 rdf:type schema:DefinedTerm
131 N1c071079223943df9e88fbb22467281b rdf:first sg:person.01100514066.14
132 rdf:rest rdf:nil
133 N2ad94e98ed124ec4bfe37dd5b2853a81 schema:name dimensions_id
134 schema:value pub.1142551074
135 rdf:type schema:PropertyValue
136 N3194d75516314c6cb0ae345299679f12 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Nitriles
138 rdf:type schema:DefinedTerm
139 N3718911293a2423eb09cd701c0d3eb09 rdf:first sg:person.010762116764.18
140 rdf:rest N07ef05031a2b4cada7b406335514a692
141 N38ba36bb720547d0a87293fd0c1353e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Protein Kinase Inhibitors
143 rdf:type schema:DefinedTerm
144 N4aa4292276e64cee83db2289ee47dc8d rdf:first sg:person.011416733702.66
145 rdf:rest N4dfee416cd5c4a04ace83508013f98e7
146 N4adb93dd858c4385ac787748106569de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Female
148 rdf:type schema:DefinedTerm
149 N4dfee416cd5c4a04ace83508013f98e7 rdf:first sg:person.01123355430.21
150 rdf:rest N61ab0b1aa9904efa98b3479dd73f55a9
151 N60ca6248b9b246b7a0207b68b3d4bf40 schema:name Springer Nature - SN SciGraph project
152 rdf:type schema:Organization
153 N61ab0b1aa9904efa98b3479dd73f55a9 rdf:first sg:person.013304036752.03
154 rdf:rest N3718911293a2423eb09cd701c0d3eb09
155 N61e8566b10c646dc88e3b78be2ce1974 schema:name pubmed_id
156 schema:value 34767056
157 rdf:type schema:PropertyValue
158 N69984f048b4749938f794193b4950deb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Pyrimidines
160 rdf:type schema:DefinedTerm
161 N6a478fec9db2450f993851b5c75d00cc schema:volumeNumber 101
162 rdf:type schema:PublicationVolume
163 N6feef059ed6c4ae99029b2f50bf72fbb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Retrospective Studies
165 rdf:type schema:DefinedTerm
166 N7a750e32bb8047e6b3354bad817b9819 rdf:first sg:person.016453003452.14
167 rdf:rest N4aa4292276e64cee83db2289ee47dc8d
168 N89c92e3040ae4942b7803718f4e38535 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Adult
170 rdf:type schema:DefinedTerm
171 N8ab76f4d28a0427b9a901f35dd7097c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Steroids
173 rdf:type schema:DefinedTerm
174 N92c6c026c4f64df28d541058592b947c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Humans
176 rdf:type schema:DefinedTerm
177 Nc790e47cca1d40dd89889a615062e380 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Graft vs Host Disease
179 rdf:type schema:DefinedTerm
180 Nc96a2237da9745d49b17fb80e74c3685 schema:issueNumber 1
181 rdf:type schema:PublicationIssue
182 Nca85650160484a0db80160ea4c19918d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Pyrazoles
184 rdf:type schema:DefinedTerm
185 Ncfc2aebad5954c40b4ec9101dc4a6c5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Male
187 rdf:type schema:DefinedTerm
188 Nd1f2065917bd430fabd822bbbf506fae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Chronic Disease
190 rdf:type schema:DefinedTerm
191 Nec5ac882f0c1445ba7b0769d18505c20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Young Adult
193 rdf:type schema:DefinedTerm
194 Nf3a185a47b7d49449648808d3942c8a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Survival Analysis
196 rdf:type schema:DefinedTerm
197 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
198 schema:name Medical and Health Sciences
199 rdf:type schema:DefinedTerm
200 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
201 schema:name Cardiorespiratory Medicine and Haematology
202 rdf:type schema:DefinedTerm
203 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
204 schema:name Clinical Sciences
205 rdf:type schema:DefinedTerm
206 sg:journal.1358129 schema:issn 0939-5555
207 1432-0584
208 schema:name Annals of Hematology
209 schema:publisher Springer Nature
210 rdf:type schema:Periodical
211 sg:person.010762116764.18 schema:affiliation grid-institutes:grid.415550.0
212 schema:familyName Lie
213 schema:givenName Albert K. W.
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010762116764.18
215 rdf:type schema:Person
216 sg:person.01100514066.14 schema:affiliation grid-institutes:grid.415550.0
217 schema:familyName Kwong
218 schema:givenName Yok-Lam
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100514066.14
220 rdf:type schema:Person
221 sg:person.01123355430.21 schema:affiliation grid-institutes:grid.415550.0
222 schema:familyName Hwang
223 schema:givenName Yu-Yan
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123355430.21
225 rdf:type schema:Person
226 sg:person.01126550300.26 schema:affiliation grid-institutes:grid.415550.0
227 schema:familyName Tse
228 schema:givenName Eric
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126550300.26
230 rdf:type schema:Person
231 sg:person.011416733702.66 schema:affiliation grid-institutes:grid.415550.0
232 schema:familyName Sim
233 schema:givenName Joycelyn P. Y.
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011416733702.66
235 rdf:type schema:Person
236 sg:person.013304036752.03 schema:affiliation grid-institutes:grid.415550.0
237 schema:familyName Chan
238 schema:givenName Thomas S. Y.
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013304036752.03
240 rdf:type schema:Person
241 sg:person.016453003452.14 schema:affiliation grid-institutes:grid.415550.0
242 schema:familyName Leung
243 schema:givenName Garret M. K.
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016453003452.14
245 rdf:type schema:Person
246 sg:pub.10.1007/s00277-020-04273-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1132407613
247 https://doi.org/10.1007/s00277-020-04273-2
248 rdf:type schema:CreativeWork
249 sg:pub.10.1038/leu.2015.212 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052129890
250 https://doi.org/10.1038/leu.2015.212
251 rdf:type schema:CreativeWork
252 sg:pub.10.1038/s41409-017-0068-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100248968
253 https://doi.org/10.1038/s41409-017-0068-2
254 rdf:type schema:CreativeWork
255 sg:pub.10.1038/s41409-017-0081-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100512173
256 https://doi.org/10.1038/s41409-017-0081-5
257 rdf:type schema:CreativeWork
258 sg:pub.10.1038/s41409-018-0204-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104393431
259 https://doi.org/10.1038/s41409-018-0204-7
260 rdf:type schema:CreativeWork
261 sg:pub.10.1038/s41409-019-0662-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1120837525
262 https://doi.org/10.1038/s41409-019-0662-6
263 rdf:type schema:CreativeWork
264 sg:pub.10.1038/s41409-019-0731-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1122362913
265 https://doi.org/10.1038/s41409-019-0731-x
266 rdf:type schema:CreativeWork
267 sg:pub.10.1038/s41409-020-0834-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1124934818
268 https://doi.org/10.1038/s41409-020-0834-4
269 rdf:type schema:CreativeWork
270 sg:pub.10.1186/s40164-017-0092-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1093138750
271 https://doi.org/10.1186/s40164-017-0092-3
272 rdf:type schema:CreativeWork
273 grid-institutes:grid.415550.0 schema:alternateName Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China
274 schema:name Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China
275 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...